Report overview
Type 1 diabetes (T1D) is an autoimmune disease that occurs when a person?s pancreas stops producing insulin, the hormone that controls blood-sugar levels. T1D develops when the insulin-producing pancreatic beta cells are mistakenly destroyed by the body?s immune system. The cause of this attack is still being researched, however scientists believe the cause may have genetic and environmental components.
This report aims to provide a comprehensive presentation of the global market for Type 1 Diabetes (T1D), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Type 1 Diabetes (T1D). This report contains market size and forecasts of Type 1 Diabetes (T1D) in global, including the following market information:
Global Type 1 Diabetes (T1D) Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Type 1 Diabetes (T1D) Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Type 1 Diabetes (T1D) companies in 2022 (%)
The global Type 1 Diabetes (T1D) market was valued at US$ 1956.2 million in 2022 and is projected to reach US$ 2644.8 million by 2029, at a CAGR of 4.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Sedentary lifestyle, unhealthy diet, lack of exercise and increasing prevalence of diabetes are key driver for Type 1 Diabetes (T1D) market. Insulin therapy is very much essential in the patients who have type 1 diabetes. Rising launch of the novel insulin formulations along with several adjunct therapies will positively impact the insulin acceptance. On the other hand, this chronic disorder poses a significant economic impact owing to the increasing cost of insulin coupled with other conditions such as cardiac disorders, kidney disease among others. While insulin therapy keeps people with T1D alive and can help keep blood-glucose levels within recommended range, it is not a cure, nor does it prevent the possibility of T1D?s serious effects. Although T1D is a serious and challenging disease, long-term management options continue to evolve, allowing those with T1D to have full and active lives. Asia Pacific region recorded the highest growth rate over the forecast period owing to the increasingly sedentary lifestyles, obese population, and improper food habits. North America accounted for more than 50% of the total market share over the forecast period.
We surveyed the Type 1 Diabetes (T1D) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Type 1 Diabetes (T1D) Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Type 1 Diabetes (T1D) Market Segment Percentages, by Type, 2022 (%)
Rapid Acting Insulin Analogs
Long Acting Insulin Analogs
Premix Insulin Analogs
Global Type 1 Diabetes (T1D) Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Type 1 Diabetes (T1D) Market Segment Percentages, by Application, 2022 (%)
Children
Adults
Global Type 1 Diabetes (T1D) Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Type 1 Diabetes (T1D) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Type 1 Diabetes (T1D) revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Type 1 Diabetes (T1D) revenues share in global market, 2022 (%)
Key companies Type 1 Diabetes (T1D) sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Type 1 Diabetes (T1D) sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novo Nordisk
Sanofi
Eli Lilly
Merck
Boehringer Ingelheim
Samsung Bioepis
Biocon
Astellas
Janssen
Bristol-Myers Squibb
Lexicon
Sanofi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Type 1 Diabetes (T1D), market overview.
Chapter 2: Global Type 1 Diabetes (T1D) market size in revenue and volume.
Chapter 3: Detailed analysis of Type 1 Diabetes (T1D) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Type 1 Diabetes (T1D) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Type 1 Diabetes (T1D) capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
